>

William Shepard - CME Independent Director

<div class='circular--portrait' style='background:#FCD202;color: white;font-size:3em;padding-top: 40px;;'>CME</div>
CME -- USA Stock  

Fiscal Quarter End: March 31, 2020  

  Director
Mr. William R. Shepard is an Independent Director of the Company. Mr. Shepard was a member of CME for more than 40 years. Previously, he served as our Second Vice Chairman from 2002 to 2007. Mr. Shepard is founder and President of Shepard International, Inc., a futures commission merchant.
Age: 71  Director Since 2007      
312-930-1000  http://www.cmegroup.com

Management Efficiency

The company has Return on Asset of 2.12 % which means that on every $100 spent on asset it made $2.12 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 8.12 % implying that it generated $8.12 on every 100 dollars invested.
The company has 3.74 B in debt with debt to equity (D/E) ratio of 14.3 . This implies that the company may be unable to create cash to meet all of its financial commitments. CME Group has Current Ratio of 1.01 demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Vincent TeseIntercontinental Exchange
2004
Steven BlackNasdaq
2011
Patrick TierneyMSCI
2010
Jochen TilkAngloGold Ashanti Limited
2019
Sheila JordanFactSet Research Systems
2016
John LeBoutillierSEMAFO INC
2018
Robert HaleMSCI
2015
Paul SturmMorningstar
1999
Benjamin DuPontMSCI
2008
Rodney RustonAngloGold Ashanti Limited
2012
Charles CrispIntercontinental Exchange
2002
Cheryl FrancisMorningstar
2002
Fred HatfieldIntercontinental Exchange
2007
David HodgsonAngloGold Ashanti Limited
2014
Terrence MartellIntercontinental Exchange
N/A
Alfred ZollarNasdaq
N/A
Maria RichterAngloGold Ashanti Limited
2015
Scott BilleadeauFactSet Research Systems
2001
Ann CairnsIntercontinental Exchange
2017
Joseph ZimmelFactSet Research Systems
2007
Essa KazimNasdaq
2008

Company Summary

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in USA and is traded on BATS Exchange.CME Group (CME) is traded on BATS Exchange in USA. It is located in 20 South Wacker Drive and employs 4,590 people. CME Group was previously known as Cme Group and was traded on BATS Exchange under the symbol MX4A. CME is listed under Trading category by Fama And French industry classification.

CME Group Leadership Team

Ana Dutra, Independent DirectorView
Daniel Glickman, Independent DirectorView
Howard Siegel, Independent DirectorView
Kathleen Cronin, Senior Managing Director, General Counsel, Corporate SecretaryView
Dennis Chookaszian, Independent DirectorView
Steven Wollack, Independent DirectorView
William Miller, Independent DirectorView
Derek Sammann, Senior Managing Director - Financial Products and ServicesView
Cees Vermaas, Managing Director & CEO of CME Europe LimitedView
Gedon Hertshten, Independent DirectorView
Elizabeth Cook, Independent TrusteeView
Daniel Kaye, DirectorView
Douglas Monieson, Independent DirectorView
William Knottenbelt, Senior Managing Director, Europe, Middle East, Africa (EMEA)View
John Pietrowhicz, Senior Managing Director - Business Development and Corporate FinanceView
Jeffrey Bernacchi, Independent DirectorView
James Oliff, Independent DirectorView
Sunil Cutinho, President - CME ClearingView
Julie Holzrichter, COO and Sr. Managing DirectorView
Timothy Bitsberger, Independent DirectorView
Bryan Durkin, Chief Commercial Officer and Sr. Managing DirectorView
Patrick Maloney, Independent DirectorView
Dennis Suskind, Independent DirectorView
Alex Pollock, Lead Independent DirectorView
Leo Melamed, Chairman EmeritusView
Charles Carey, Vice Chairman of the BoardView
Hilda Piell, Chief Human Resource Officer, Senior Managing DirectorView
Kimberly Taylor, President of Global Operations, Technology and RiskView
David Wescott, Independent DirectorView
Edemir Pinto, Independent DirectorView
Deborah Lucas, Independent DirectorView
John Sandner, DirectorView
Jack Tobin, Chief Accounting Officer, Managing DirectorView
Larry Gerdes, Independent DirectorView
Phupinder Gill, CEO, Director, Member of Competitive Markets Advisory Council, Member of Executive Committee and Member of Strategic Steering CommitteeView
Linda Rich, Senior Managing Director - Government Relations and Legislative AffairsView
Terry Savage, Independent DirectorView
Bruce Johnson, Independent DirectorView
Julie Winkler, Senior Managing Director - Research and Product DevelopmentView
Ronald Pankau, Independent DirectorView
Kevin Kometer, CIO, Senior Managing DirectorView
Robert Zagotta, Senior Managing Director - Products and ServicesView
Yra Harris, DirectorView
Terrence Duffy, Executive Chairman and President Member of Competitive Markets Advisory Council, Chairman of Executive Committee and Member of Strategic Steering CommitteeView
Michael Spencer, DirectorView
Martin Gepsman, Independent DirectorView
William Hobert, Independent TrusteeView
Sean Tully, Senior Managing Director - Interest Rates, OTC ProductsView
William Shepard, Independent DirectorView

Stock Performance Indicators

Current Sentiment - CME

CME Group Investor Sentiment

Greater number of Macroaxis users are currently bullish on CME Group. What is your opinion about investing in CME Group? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

CME Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for CME and SEMAFO INC. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Please also try Instant Ratings module to determine any equity ratings based on digital recommendations. macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.